Endogenous Retrovirus-Targeted Immunotherapy for Non-Small Cell Lung Cancer Supported by Cellular HERV-K Expression, Dependency and Efficacy of ERV Therapy in a Murine Model
International Journal of Molecular Sciences · 29.10.2026 · 27 (21) · 9717
DOI: 10.3390/ijms27219717 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2026. Verfasst von Maria Perez-Penco und 10 weiteren Autor:innen. Beteiligte Einrichtung: HERVolution Therapeutics, Symbion, 2000 Frederiksberg, Denmark. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Endogenous Retroviruses, Lung Neoplasms, Immunotherapy. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Innovation Council, European Innovation Council Accelerator, European Innovation Council Eurostars.
Abstract (Originalsprache)
Human endogenous retrovirus-K (HERV-K/HML-2) has been associated with non-small cell lung cancer (NSCLC), but its functional relevance and the potential for HERV-directed immunotherapy remains unresolved. Here, we characterized HERV-K expression across 207 advanced NSCLC patient biopsies by total RNA-seq observing widespread expression of HERV-K Gag and Env antigen encoding sequences. The Env-ORF that disrupted HERV-K102 was strongly associated with interferon and antigen-presenting programs, identifying it as a marker of an immune-activated tumor state. shRNA-mediated knockdown of HERV-K in five NSCLC cell lines with distinct driver mutations impaired proliferation and survival. In separate experiments, exposure of these cell lines to treatment-related stressors, including cytokines (TNF-α and IFN-γ) and chemotherapy, revealed dynamic patterns of HERV-K protein accumulation with antigen expression retained, and in some cases increased. Immunotherapeutic targeting was performed using the ASB-XIV mouse NSCLC cell line and a murine ERV surrogate antigen using adenovirus to express murine leukemia virus (MLV) antigen on a mouse β-retroviral particle structurally related to HERV-K. This immunization was able to elicit significant protection against tumor challenge and additive benefit with anti-PD-L1 in therapeutic treatment, establishing proof-of-concept for ERV-targeted immunotherapy in a murine surrogate system rather than direct evidence of HERV-K-targeted efficacy. Our findings suggest an important role of HERV-K in NSCLC immunobiology and that adaptive immunity targeting HERV-K should be explored in the treatment of NSCLC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HERVolution Therapeutics, Symbion, 2000 Frederiksberg, Denmark.
- MDxCORE, Copenhagen University Hospital (Rigshospitalet), 2100 Copenhagen, Denmark.
- Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
ORCID-Profile: Tara Elizabeth Scott, Emilie Sofie Engdal, Gabriel Mira González, Lea Klingenberg Barfod, Kristoffer Staal Rohrberg, Frederik Otzen Bagger, Lasse Neukirch, Anne-Marie Carola Andersson
Förderung
- European Innovation Council
- European Innovation Council Accelerator
- European Innovation Council Eurostars
Zitieren
APA
Perez-Penco, M., Scott, T. E., Engdal, E. S., Picon Jara, C., González, G. M., Barfod, L. K., Rohrberg, K. S., Bagger, F. O., Neukirch, L., Andersson, A. C., & Holst, P. J. (2026). Endogenous Retrovirus-Targeted Immunotherapy for Non-Small Cell Lung Cancer Supported by Cellular HERV-K Expression, Dependency and Efficacy of ERV Therapy in a Murine Model. International Journal of Molecular Sciences, 27(21), 9717. https://doi.org/10.3390/ijms27219717
Vancouver
Perez-Penco M, Scott TE, Engdal ES, Picon Jara C, González GM, Barfod LK, et al. Endogenous Retrovirus-Targeted Immunotherapy for Non-Small Cell Lung Cancer Supported by Cellular HERV-K Expression, Dependency and Efficacy of ERV Therapy in a Murine Model. International Journal of Molecular Sciences. 2026;27(21):9717. doi:10.3390/ijms27219717
BibTeX
@article{PerezPenco2026,
author = {Perez-Penco, Maria and Scott, Tara Elizabeth and Engdal, Emilie Sofie and Picon Jara, Cristina and González, Gabriel Mira and Barfod, Lea Klingenberg and Rohrberg, Kristoffer Staal and Bagger, Frederik Otzen and Neukirch, Lasse and Andersson, Anne-Marie Carola and Holst, Peter Johannes},
title = {Endogenous Retrovirus-Targeted Immunotherapy for Non-Small Cell Lung Cancer Supported by Cellular HERV-K Expression, Dependency and Efficacy of ERV Therapy in a Murine Model},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9717},
doi = {10.3390/ijms27219717}
}
EUVIMED